AksharChem India [AKSHARCHEM] vs Chemo-Pharma [CPL] Detailed Stock Comparison

AksharChem India

NSE

Chemo-Pharma

BSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: AksharChem India wins in 8 metrics, Chemo-Pharma wins in 10 metrics, with 0 ties. Chemo-Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	AksharChem India	Chemo-Pharma	Better
P/E Ratio (TTM)	48.36	13.42	Chemo-Pharma
Price-to-Book Ratio	0.79	2.77	AksharChem India
Debt-to-Equity Ratio	25.32	44.70	AksharChem India
PEG Ratio	-0.39	N/A	N/A
EV/EBITDA	11.14	14.73	AksharChem India
Profit Margin (TTM)	1.21%	10.92%	Chemo-Pharma
Operating Margin (TTM)	2.50%	10.65%	Chemo-Pharma
EBITDA Margin (TTM)	2.50%	10.65%	Chemo-Pharma
Return on Equity	1.81%	25.59%	Chemo-Pharma
Return on Assets (TTM)	1.15%	6.80%	Chemo-Pharma
Free Cash Flow (TTM)	$-93.80M	$41.66M	Chemo-Pharma
Dividend Yield	0.20%	N/A	N/A
1-Year Return	-18.80%	4.91%	Chemo-Pharma
Price-to-Sales Ratio (TTM)	0.59	1.55	AksharChem India
Enterprise Value	$2.74B	$4.74B	Chemo-Pharma
EV/Revenue Ratio	0.77	1.65	AksharChem India
Gross Profit Margin (TTM)	42.61%	31.19%	AksharChem India
Revenue per Share (TTM)	$446	$52	AksharChem India
Earnings per Share (Diluted)	$5.40	$5.54	Chemo-Pharma
Beta (Stock Volatility)	0.17	0.22	AksharChem India

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

AksharChem India vs Chemo-Pharma Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
AksharChem India	-1.03%	-9.93%	-12.45%	14.82%	-0.54%	-15.64%
Chemo-Pharma	1.47%	2.47%	-1.75%	-8.21%	-29.42%	-35.67%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
AksharChem India	-18.80%	-6.10%	14.26%	-64.45%	-64.45%	-64.45%
Chemo-Pharma	4.91%	356.22%	106.97%	967.33%	1,361.33%	1,361.33%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

AksharChem India (AKSHARCHEM): View Full Stock Overview

Chemo-Pharma (CPL): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: AksharChem India vs Chemo-Pharma

Metric	AKSHARCHEM	CPL
Market Information
Market Cap i	₹2.11B	₹4.45B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	8,947	31,814
90 Day Avg. Volume i	14,365	37,628
Last Close	₹258.45	₹75.92
52 Week Range	₹195.00 - ₹368.10	₹59.05 - ₹128.00
% from 52W High	-29.79%	-40.69%
All-Time High	₹945.00 (May 15, 2017)	₹128.00 (Jan 06, 2025)
% from All-Time High	-72.65%	-40.69%
Growth Metrics
Quarterly Revenue Growth	0.13%	0.14%
Quarterly Earnings Growth	-0.38%	-0.04%
Financial Health
Profit Margin (TTM) i	0.01%	0.11%
Operating Margin (TTM) i	0.03%	0.11%
Return on Equity (TTM) i	0.02%	0.26%
Debt to Equity (MRQ) i	25.32	44.70
Cash & Liquidity
Book Value per Share (MRQ)	₹328.90	₹26.86
Cash per Share (MRQ)	₹2.25	₹1.07
Operating Cash Flow (TTM) i	₹66.50M	₹89.49M
Levered Free Cash Flow (TTM) i	₹47.70M	₹-72,916,248
Dividends
Last 12-Month Dividend Yield i	0.20%	N/A
Last 12-Month Dividend i	₹0.50	₹0.00

Valuation & Enterprise Metrics Analysis: AksharChem India vs Chemo-Pharma

Metric	AKSHARCHEM	CPL
Price Ratios
P/E Ratio (TTM) i	48.36	13.42
Forward P/E i	N/A	N/A
PEG Ratio i	-0.39	N/A
Price to Sales (TTM) i	0.59	1.55
Price to Book (MRQ) i	0.79	2.77
Market Capitalization
Market Capitalization i	₹2.11B	₹4.45B
Enterprise Value i	₹2.74B	₹4.74B
Enterprise Value Metrics
Enterprise to Revenue i	0.77	1.65
Enterprise to EBITDA i	11.14	14.73
Risk & Other Metrics
Beta i	0.17	0.22
Book Value per Share (MRQ) i	₹328.90	₹26.86

Financial Statements Comparison: AksharChem India vs Chemo-Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	AKSHARCHEM	CPL
Revenue/Sales i	₹907.38M	₹784.51M
Cost of Goods Sold i	₹531.85M	₹539.82M
Gross Profit i	₹375.54M	₹244.69M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹27.47M	₹83.57M
EBITDA i	₹61.73M	₹98.07M
Pre-Tax Income i	₹12.98M	₹68.08M
Income Tax i	₹-891,000	₹16.93M
Net Income (Profit) i	₹13.87M	₹51.16M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	AKSHARCHEM	CPL
Cash & Equivalents i	₹1.44M	₹12.05M
Total Current Assets i	₹1.34B	₹2.51B
Total Current Liabilities i	₹1.15B	₹1.17B
Long-Term Debt i	₹133.16M	₹109.50M
Total Shareholders Equity i	₹2.64B	₹1.49B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹2.31B	₹144.04M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	AKSHARCHEM	CPL
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	AKSHARCHEM	CPL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	8,947	31,814
Average Daily Volume (90 Day) i	14,365	37,628
Shares Outstanding i	8.03M	57.55M
Float Shares i	2.29M	16.11M
% Held by Insiders i	0.70%	0.70%
% Held by Institutions i	0.00%	0.00%

Dividend Analysis & Yield Comparison: AksharChem India vs Chemo-Pharma

Metric	AKSHARCHEM	CPL
Last 12-Month Dividend i	₹0.50	₹0.00
Last 12-Month Dividend Yield i	0.20%	N/A
3-Year Avg Annual Dividend i	₹0.50	₹0.00
3-Year Avg Dividend Yield i	0.15%	N/A
3-Year Total Dividends i	₹1.50	₹0.00
Ex-Dividend Date	Sep 23, 2024	N/A

AksharChem India [AKSHARCHEM] vs Chemo-Pharma [CPL] Detailed Stock Comparison